Girish Putcha, MD, PhD

home / authors / girish-putcha-md-phd

Articles

Dr. Putcha on the Utility of Blood-Based Assays in CRC

Dr. Putcha on the Utility of Blood-Based Assays in CRC

Girish Putcha, MD, PhD
March 14th 2020

Girish Putcha, MD, PhD, discusses the utility of blood-based assays in colorectal cancer.

Read More

Dr. Putcha on the Results of the AI EMERGE Trial in CRC

Dr. Putcha on the Results of the AI EMERGE Trial in CRC

Girish Putcha, MD, PhD
February 14th 2020

Girish Putcha, MD, PhD, discusses the results of the AI EMERGE trial (NCT03688906) in colorectal cancer.

Read More

Dr. Putcha on Blood-Based Detection of Early-Stage CRC

Dr. Putcha on Blood-Based Detection of Early-Stage CRC

Girish Putcha, MD, PhD
February 6th 2020

Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses blood-based detection of early-stage colorectal cancer (CRC) using multiomics and machine learning.

Read More

Dr. Putcha on the Use of Blood-Based Screening Assays in CRC

Dr. Putcha on the Use of Blood-Based Screening Assays in CRC

Girish Putcha, MD, PhD
February 5th 2020

Girish Putcha, MD, PhD, discusses the use of blood-based screening assays in colorectal cancer (CRC).

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data